Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the market right now?

In recent times, there has been a robust expansion of the superdisintegrants market size. The market which was valued at $1.09 billion in 2024 is predicted to increase to $1.16 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.5%. Factors such as the escalating incidence of lifestyle and chronic illnesses, expansion in the worldwide pharmaceutical sector, growing demand for orally disintegrating tablets (ODTs), an increase in the aging and young populations, and a heightened emphasis on enhancing drug bioavailability have all contributed to the growth experienced in the historic period.

How fast Is the market expected to grow, and what’s its future value?

In the coming years, the market size of superdisintegrants is anticipated to experience robust growth. The market is projected to escalate to a valuation of $1.48 billion by 2029, with a compound annual growth rate (CAGR) of 6.3%. This growth in the forecast period can be linked to the growing need for oral solid dosage forms, an increase in chronic disease occurrence, a surge in pharmaceutical manufacturing, and rising demand for oral solid dosage forms. The predicted forecasts for this period show a trend of technological innovation in production processes, advances in co-processed excipients leaning towards natural and biodegradable superdisintegrants, the emergence of innovative drug-delivery systems, and increased partnerships between pharmaceutical companies and excipients.

Get your market report here!

https://www.thebusinessresearchcompany.com/report/superdisintegrants-global-market-report

Which key drivers are propelling the market’s growth?

The superdisintegrants market is predicted to flourish due to the escalated production of generic drugs. Generic drugs, which possess identical attributes such as active ingredients, dosage, strength, administration route, quality and performance to those of their brand-name counterparts, but are typically cheaper, are becoming more prevalent. This increase is spurred by a growing demand for cost-effective medication, as well as patent expirations of trademarked drugs and governmental strategies aimed at minimising healthcare expenses. Superdisintegrants improve the disintegration and dissolution of tablets in generic drugs, resulting in quicker drug release, enhanced bioavailability, and increased patient compliance. For example, a January 2023 report by the Food and Drug Administration, an American governmental agency, stated that in 2022, an estimated 91% of US prescriptions were filled with generic drugs, with the Food and Drug Administration approving over 32,000 generic medications to date. Thus, the burgeoning production of generic drugs is fuelling the superdisintegrants market’s expansion.

What are the key segments defining the market?

The superdisintegrants market covered in this report is segmented –

1) By Type: Natural Superdisintegrants, Synthetic Superdisintegrants, Other Superdisintegrants

2) By Formulation: Tablets, Capsules

3) By Therapeutic Area: Gastrointestinal Diseases, Neurological Diseases, Oncology, Infectious Diseases, Cardiovascular Diseases, Hematological Diseases

Subsegments:

1) By Natural Superdisintegrants: Starch, Cellulose, Chitosan, Gums, Other Natural Superdisintegrants

2) By Synthetic Superdisintegrants: Cross-linked Polyvinylpyrrolidone (Crospovidone), Sodium Starch Glycolate, Croscarmellose Sodium, Other Synthetic Superdisintegrants

3) By Other Superdisintegrants: Ion Exchange Resins, Surfactant-Based Superdisintegrants, Other Specialized Superdisintegrants

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21292&type=smp

Who are the key players steering the development of the market?

Major companies operating in the superdisintegrants market are BASF SE, Merck KGaA, DuPont de Nemours Inc., IFF Pharma Solutions, Ingredion Incorporated, Roquette Freres SA., FMC Corporation, Azelis Group, Ashland Inc., Piramal Healthcare, Colorcon Inc. Ltd., Boai NKY Pharmaceuticals Ltd., JRS Pharma, Faran Shimi Pharmaceutical, DFE Pharma India Private Limited., Sigachi Industries Limited, Corel Pharma Chem, Maple Biotech Pvt. Ltd., Shanghai Chineway Pharmaceutical Technology Co. Ltd., JH Nanhang Life Sciences Co. Ltd.

What emerging trends are influencing the growth of the market?

Key players in the superdisintegrants market are concentrating on innovative products such as multifunctional disintegrants. These are designed to boost the efficacy of drug formulation, quicken tablet disintegration, and ensure patient compliance in pharmaceutical applications. A multifunctional disintegrant is a sophisticated ingredient that combines disintegration, binding, and flow improvement characteristics to enhance tablet formulation productivity and drug release. In one instance, Ashland Inc., an American chemical company, introduced Polyplasdone Plus in June 2023. This co-processed multifunctional direct compression superdisintegrant aims to improve tablet disintegration, powder flow, and lubrication in pharmaceutical manufacturing processes. The new offering simplifies production by removing two manufacturing stages, fortifies tablet strength and accommodates high-velocity and ongoing production cycles.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21292

Which regions are most influential in expanding the market?

North America was the largest region in the superdisintegrants market in 2024. The regions covered in the superdisintegrants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Diabetic Kidney Disease Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Kidney Transplant Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report

Chronic Kidney Disease Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: